VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ARCT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ARCTArcturus Therapeutics Holdings Inc.
$10.35$294M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksARCTQuarterly Cash Flow

Arcturus Therapeutics Holdings Inc. (ARCT) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Arcturus Therapeutics Holdings Inc. (ARCT) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

ARCT Cash Flow Statement

Quarterly statement

ARCT Cash Flow Statement

Arcturus Therapeutics Holdings Inc. (ARCT) cash flow statement — 15-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Cash from Operations-6.91M-19.91M-19.44M-16.23M-17.15M-5.75M-35.14M-284K-23.76M-30.14M-5.56M-629K-32.41M50.81M-35.87M160.26M-42.41M-36.82M-49.04M-42.5M
Operating CF Margin %-37.74%-672.86%-3187.05%-526.68%-100%-23.48%-119.59%-1.35%-61.22%-65.56%-17.05%-2.51%-74.71%483%-44.68%99.98%-317.2%-135.91%-935.14%-733.47%
Operating CF Growth %59.74%-245.96%44.67%-5613.73%27.83%80.91%-532.32%54.85%26.67%-159.33%84.51%-100.39%23.58%237.98%26.85%477.11%-154.64%-11.77%-14.18%-540.79%
Net Income-7.41M-23.79M-26.96M-29.08M-13.45M-9.18M-14.08M-30M-6.9M-17.22M-26.82M-11.71M-16.22M-52.55M50.75M117.35M-35.27M-21.56M-51.17M-38.66M
Depreciation & Amortization601K643K658K682K763K779K801K819K912K909K904K815K827K737K578K551K417K335K224K310K
Stock-Based Compensation4.04M4.23M4.33M6.82M5.73M6.2M6.66M8.98M9.49M9.42M10.09M8.81M9.27M8.38M8.18M6.53M9.44M7.27M7.37M7.52M
Deferred Taxes00000000000000000000
Other Non-Cash Items-2.62M61K-33K2.39M170K128K21K-172K202K388K53K013.82M0-33.29M1.63M2.44M-32.73M772K1.41M
Working Capital Changes-1.51M-1.06M2.57M2.96M-10.37M-3.68M-28.55M20.09M-27.47M-23.65M10.21M1.45M-40.1M94.24M-62.09M34.21M-19.43M9.86M-6.24M-13.07M
Change in Receivables564K-470K4.22M2.47M9.25M-2.63M-10.6M26.23M-6.11M2.97M5.01M6.16M-35.42M89.68M-89.72M-720K203K1.44M-324K-1.35M
Change in Inventory00000000000000000000
Change in Payables1.35M321K-142K-1.45M-5.04M4.44M-1.01M-2.94M-3.77M4.76M3.87M-12.73M0-6.2M11.79M-8.45M9.76M0-44K1.8M
Cash from Investing-52K18K34K87.34K-181K0-137K0-80K-328K-240K-875K-981K-354K-691K-3.81M-2.19M378K-2.11M-1.12M
Capital Expenditures000-137.66K-181K0-137K0-80K-328K-240K-875K-981K-354K-691K-3.81M-2.19M378K-2.11M-1.12M
CapEx % of Revenue---4.47%1.06%-0.47%-0.21%0.71%0.74%3.49%2.26%3.37%0.86%2.38%16.35%1.4%40.26%19.3%
Acquisitions0-34K34K00000000000000000
Investments--------------------
Other Investing-52K52K0225K0000000000000000
Cash from Financing291K016K11.69M1.23M-14.73M15.2M134K693K2.4M2.19M-18.66M21.84M94K-27.36M-2.23M-1.22M257K336K230K
Debt Issued (Net)00000015M0000-20M00-27.36M-3M-2M000
Equity Issued (Net)0016K12.42M0000000000000000
Dividends Paid00000000000000000000
Share Repurchases00000000000000000000
Other Financing291K00-733.68K1.23M-14.73M195K134K693K2.4M2.19M1.34M21.84M94K0768K780K257K336K230K
Net Change in Cash-6.67M-19.89M-19.39M-4.45M-16.11M-20.48M-20.08M-150K-23.15M-28.07M-3.61M-20.16M-11.55M50.55M-63.93M154.22M-45.81M-36.19M-50.81M-43.38M
Free Cash Flow-6.91M-19.91M-19.44M-16.36M-17.33M-5.75M-35.27M-284K-23.84M-30.47M-5.8M-1.5M-33.39M50.45M-36.56M156.45M-44.59M-36.44M-51.15M-43.62M
FCF Margin %-37.74%-672.86%-3187.05%-531.15%-101.06%-23.48%-120.06%-1.35%-61.43%-66.27%-17.78%-6%-76.97%479.64%-45.54%97.6%-333.55%-134.51%-975.4%-752.76%
FCF Growth %60.16%-245.96%44.89%-5662.2%27.31%81.11%-508.5%81.12%28.58%-160.39%84.14%-100.96%25.13%238.44%28.52%458.71%-142.1%-9.28%-18.77%-495.1%
FCF per Share-0.24-0.70-0.68-0.60-0.64-0.21-1.30-0.01-0.88-1.13-0.22-0.06-1.261.90-1.355.78-1.68-1.38-1.94-1.65
FCF Conversion (FCF/Net Income)-3.89x0.84x0.72x0.56x1.28x0.63x2.50x0.01x3.44x1.75x0.21x0.05x2.00x-0.97x-0.71x1.37x1.20x1.71x0.96x1.10x
Interest Paid0000000000025K002.1M228K230K186K169K511K
Taxes Paid00000000000000000000